Oklahoma 2026 Regular Session Status: In Committee 2 D cosponsors

HB 1019 — Public health; Oklahoma Rare Disease Advisory Council; purpose; appointment procedures; membership requirements; annual report; membership terms; vacancies; term; effective date.

Last action — Referred to Appropriations and Budget Health Subcommittee

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced February 03, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Prognosis

Stalled 18% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 2 sponsors

    2 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (2 D).

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

What changed in the latest version

160 added · 236 removed

Plain-language change summary

The amendments to HB 1019 involve a complete rework of the bill's text, removing the original content and replacing it with a new framework for establishing the Oklahoma Rare Disease Advisory Council. This new version outlines the purpose and activities of the council, emphasizing its role in supporting public health related to rare diseases. The change is significant because it officially sets up a platform for addressing the needs and challenges of individuals affected by rare diseases in Oklahoma, promoting better resources and awareness in this area.

→
Previous
Latest
STATE OF OKLAHOMA 2 1st Session of the 60th Legislature (2025) 3 HOUSE BILL 1019 By:
HB1019 SUBPCS1 Michelle McCane-TJ 2/13/2025 1:57:19 pm COMMITTEE AMENDMENT HOUSE OF REPRESENTATIVES State of Oklahoma SPEAKER:
McCane 4 5 AS INTRODUCED 7 An Act relating to public health;
CHAIR:
I move to amend HB1019 Of the printed Bill Page Section Lines Of the Engrossed Bill By deleting the content of the entire measure, and by inserting in lieu thereof the following language:
AMEND TITLE TO CONFORM TO AMENDMENTS Amendment submitted by:
Michelle McCane Adopted:
_____________________________ ______________________Reading Clerk___ STATE OF OKLAHOMA 1st Session of the 60th Legislature (2025) PROPOSED SUBCOMMITTEE SUBSTITUTE FOR HOUSE BILL NO.
1019 By:
McCane 6 8 PROPOSED SUBCOMMITTEE SUBSTITUTE An Act relating to public health;
providing for per diem expenses;
The Oklahoma Rare Disease Advisory Council shall be established within the State Department of Health in accordance with this section.
There is hereby created within the State Department of Health the Oklahoma Rare Disease Advisory Council.
The purpose of the Council shall be to provide guidance and recommendations to educate the public, the Legislature, and other state agencies, as appropriate, on the needs of individuals with rare diseases living in this state.
The purpose of the Council shall be to provide guidance and recommendations to educate the public, the Legislature, and other Req.
Req.
11095 Page 1 C.
12482 Page 1 state agencies, as appropriate, on the needs of individuals with rare diseases living in this state.
The Council shall conduct the following activities to 2 benefit those impacted by rare diseases in this state:
C.
3 1.
The Council shall conduct the following activities to benefit those impacted by rare diseases in this state:
Convene public hearings, make inquiries, and solicit comments from the general public in Oklahoma to assist the Council 5 with a first-year landscape or survey of the needs of rare disease 6 patients, caregivers, and providers in the state;
1.
7 2.
Convene public hearings, make inquiries, and solicit comments from the general public in Oklahoma to assist the Council with a first-year landscape or survey of the needs of rare disease patients, caregivers, and providers in the state;
Provide testimony and comments on pending legislation and 8 regulations before the Legislature, if called, and other state agencies that impact Oklahoma's rare disease community;
2.
Provide testimony and comments on pending legislation and regulations before the Legislature, if called, and other state agencies that impact Oklahoma's rare disease community;
Identify areas of unmet need for research and opportunities for collaboration across stakeholders and other state rare disease advisory councils that can inform future studies and work done by the Council;
Identify areas of unmet need for research and opportunities for collaboration across stakeholders and other state rare disease Req.
and Req.
11095 Page 2 6.
12482 Page 2 advisory councils that can inform future studies and work done by the Council;
Research and identify best practices to reduce health 2 disparities and achieve health equity in the research, diagnosis, 3 and treatment of rare disease in this state.
and 6.
Research and identify best practices to reduce health disparities and achieve health equity in the research, diagnosis, and treatment of rare disease in this state.
The Council's appointment process shall be conducted in 5 a transparent manner to provide interested individuals an 6 opportunity to apply for membership on the Council.
The Council's appointment process shall be conducted in a transparent manner to provide interested individuals an opportunity to apply for membership on the Council.
All members of 7 the Council shall be full-time residents of this state as 8 practicable.
All members of the Council shall be full-time residents of this state as practicable.
The Chair shall appoint no fewer than seventeen (17) members, including the following:
The Governor shall appoint seven (7) members:
one representative of an academic research institution in the state that receives any grant funding for rare disease research, b.
two patients who have a rare disease, b.
one representative of the State Department of Health's Office of Minority Health and Health Equity, or successor division, c.
two caregivers of a person with a rare disease, c.
one representative of the Oklahoma Health Care Authority, d.
one representative of the biopharmaceutical industry, d.
one representative of the Insurance Department, Req.
one representative of a rare disease patient organization that operates in this state, and e.
No.
one representative of a health plan company.
11095 Page 3 e.
4.
one registered nurse or Advanced Practice Registered 2 Nurse licensed and practicing in this state with 3 experience treating rare diseases, f.
The State Department of Health shall appoint five (5) members:
one physician practicing in this state with experience 5 treating rare diseases, 6 g.
one geneticist or genetic counselor, 7 h.
one hospital administrator, or his or her designee, 8 from a hospital in this state that provides care to persons diagnosed with a rare disease, i.
at least two patients who have a rare disease, j.
at least one caregiver of a person with a rare disease, k.
one representative of a rare disease patient organization that operates in this state, l.
Show all 80 changed rows (40 more)
Previous
Latest
one pharmacist with experience dispensing drugs used to treat rare diseases, m.
one representative of the biopharmaceutical industry, n.
one representative of a health plan company, o.
one member of the scientific community who is engaged in rare disease research including, but not limited to, a medical researcher with experience conducting research on rare diseases, and p.
one mental health provider with experience treating rare disease patients in this state.
11095 Page 4 E.
12482 Page 3 a.
one representative of the State Department of Health's Office of Minority Health and Health Equity, or successor division, b.
one registered nurse or Advanced Practice Registered Nurse licensed and practicing in this state with experience treating rare diseases, c.
one physician practicing in this state with experience treating rare diseases, d.
one pharmacist with experience dispensing drugs used to treat rare diseases, and e.
one member of the scientific community who is engaged in rare disease research including, but not limited to, a medical researcher with experience conducting research on rare diseases.
5.
The Oklahoma Health Care Authority shall appoint two (2) members:
a.
one representative of the Oklahoma Health Care Authority, and b.
one geneticist or genetic counselor.
6.
The Department of Mental Health and Substance Abuse Services shall appoint one member who is a mental health provider with experience treating rare disease patients in this state.
7.
The State Regents for Higher Education shall appoint one member who is a representative of an academic research institution Req.
No.
12482 Page 4 in the state that receives any grant funding for rare disease research.
E.
The Council shall electronically submit a report to the 2 President Pro Tempore of the Oklahoma State Senate, the Speaker of 3 the Oklahoma House of Representatives, and the Governor within one (1) year of establishment of the Oklahoma Rare Disease Advisory 5 Council and annually thereafter.
The Council shall electronically submit a report to the President Pro Tempore of the Oklahoma State Senate, the Speaker of the Oklahoma House of Representatives, and the Governor within one (1) year of establishment of the Oklahoma Rare Disease Advisory Council and annually thereafter.
Prior to submission, a draft of 6 the annual report shall be made available for public comment and 7 discussed at an open public meeting.
Prior to submission, a draft of the annual report shall be made available for public comment and discussed at an open public meeting.
8 2.
2.
G.
Req.
No.
12482 Page 5 G.
At the end of the chair's initial three-year Req.
At the end of the chair's initial three-year term, and every two (2) years thereafter, members of the Council shall elect, by a majority vote, a new chair.
No.
2.
11095 Page 5 term, and every two (2) years thereafter, members of the Council 2 shall elect, by a majority vote, a new chair.
Council members shall serve no longer than three (3) years, except that, to facilitate a staggered rotation of members to retain continuity and knowledge transfer, during the initial five (5) years after the establishment of the Council, members may serve up to a four-year term.
3 2.
3.
Council members shall serve no longer than three (3) years, except that, to facilitate a staggered rotation of members to retain 5 continuity and knowledge transfer, during the initial five (5) years 6 after the establishment of the Council, members may serve up to a 7 four-year term.
8 3.
As used in this section, "rare disease", sometimes called an orphan disease, means a disease that affects fewer than two hundred thousand (200,000) people in the United States.
As used in this section, "rare disease", also known as an orphan disease, means a disease that affects fewer than two hundred thousand (200,000) people in the United States.
I.
The members of the Council shall be paid a per diem in accordance with the State Travel Reimbursement Act when attending Council meetings or other activities associated with the duties of the Council members.
60-1-11095 TJ 12/13/24 Req.
60-1-12482 TJ 02/13/25 Req.
11095 Page 6
12482 Page 6
View plain text versions (2)

Action History

  1. Referred to Appropriations and Budget Health Subcommittee

  2. Referred to Appropriations and Budget

  3. Withdrawn from Rules Committee

  4. Referred to Rules

  5. Withdrawn from Appropriations and Budget Committee

  6. Second Reading referred to Appropriations and Budget

  7. Authored by Representative McCane

  8. First Reading

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

2 sponsors · 0 co-sponsors · 149 not signed on

Sponsors (2)

Co-sponsors (0)

None.

Not signed on (149)

149 members have not signed on to this bill.

Show all 149 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 1019?
HB 1019 is sponsored by Michelle McCane (Democrat) and Carri Hicks (Democrat).
What is the current status of HB 1019?
This bill is in committee in the House. Introduced February 03, 2025. It must pass committee before a floor vote.
Where can I track HB 1019?
Track HB 1019 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 1019

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 1019

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →